LEADER 01233nam  2200361Ia 450 
001 9910697097503321
005 20230902161637.0
035   $a(CKB)5470000002383922
035   $a(OCoLC)574588322
035   $a(EXLCZ)995470000002383922
100   $a20100326d1998      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $ePAC-ATLS : postapproval changes, analytical testing laboratory sites
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,$d[1998]
215   $a1 electronic resource (3 pages)
300   $a"CMC 10."
300   $a"April 1998."
517   $aGuidance for industry 
606   $aDrugs$zUnited States$xTesting
606   $aLaboratories$xGovernment policy$zUnited States
615  0$aDrugs$xTesting.
615  0$aLaboratories$xGovernment policy
712 02$aCenter for Drug Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910697097503321
996   $aGuidance for industry$93434577
997   $aUNINA